
    
      2000 patients with positive tumor protein markers or cancer screening were recruited. All
      patients were tested for ctDNA at enrollment and followed up at 6 months and 1 year. The
      study was completed at the time of cancer diagnosis or the longest follow-up time (1 year).
    
  